tradingkey.logo

Bausch + Lomb Corp

BLCO
查看詳細走勢圖
17.000USD
+0.590+3.60%
收盤 02/06, 16:00美東報價延遲15分鐘
6.02B總市值
虧損本益比TTM

Bausch + Lomb Corp

17.000
+0.590+3.60%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+3.60%

5天

+1.80%

1月

-0.70%

6月

+20.48%

今年開始到現在

-0.47%

1年

+5.85%

查看詳細走勢圖

TradingKey Bausch + Lomb Corp股票評分

單位: USD 更新時間: 2026-02-06

操作建議

Bausch + Lomb Corp當前公司基本面數據相對穩定,最新ESG揭露屬於行業領先水平。增長潛力很大。當前估值合理,在醫療設備與耗材行業排名83/205位。機構持股佔比非常高,近一月多位分析師給出公司評級為持有。最高目標價為17.33。中期看,股價處於平穩狀態。近一個月,市場表現一般,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Bausch + Lomb Corp評分

相關信息

行業排名
83 / 205
全市場排名
222 / 4521
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
看空

Bausch + Lomb Corp亮點

亮點風險
Bausch + Lomb Corporation is an eye health company. It operates through three segments: Vision Care, Pharmaceuticals, and Surgical. Vision Care segment includes both a contact lens and a consumer eye care business that consists of contact lens care products, over-the-counter eye drops and eye vitamins. Pharmaceuticals segment consists of generic pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. Surgical segment consists of medical device equipment, consumables, instruments and technologies for the treatment of cataracts, corneal and vitreous and retinal eye conditions, which includes delivery systems, phacoemulsification equipment and other surgical instruments and devices for cataract surgery. Its brands consist of PreserVision, Biotrue, Artelac, Alaway, Mioclear, Ocuvite, ScoutPro, XIIDRA, Vyzulta, Lotemax, Prolensa, Minims, INFUSE, and many more.
業績高增長
公司營業收入穩步增長,連續3年增長27.15%
估值合理
公司最新PE估值-19.71,處於3年歷史合理位
機構加倉
最新機構持股42.63M股,環比增加0.03%
霍華·馬克斯持倉
明星投資者霍華·馬克斯持倉,最新持倉3.25M股

分析師目標

基於 13 分析師
持有
評級
17.333
目標均價
+5.63%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Bausch + Lomb Corp新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Bausch + Lomb Corp簡介

Bausch + Lomb Corporation is an eye health company. It operates through three segments: Vision Care, Pharmaceuticals, and Surgical. Vision Care segment includes both a contact lens and a consumer eye care business that consists of contact lens care products, over-the-counter eye drops and eye vitamins. Pharmaceuticals segment consists of generic pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. Surgical segment consists of medical device equipment, consumables, instruments and technologies for the treatment of cataracts, corneal and vitreous and retinal eye conditions, which includes delivery systems, phacoemulsification equipment and other surgical instruments and devices for cataract surgery. Its brands consist of PreserVision, Biotrue, Artelac, Alaway, Mioclear, Ocuvite, ScoutPro, XIIDRA, Vyzulta, Lotemax, Prolensa, Minims, INFUSE, and many more.
公司代碼BLCO
公司Bausch + Lomb Corp
CEOSaunders (Brenton L)
網址https://ir.bausch.com/
KeyAI